Novel monogalactoside galectin inhibitor scaffolds : Guiding selectivity with heteroaromatic interactions

Abstract

Carbohydrates are involved in many cellular processes, and most biomolecules are glycosylated. These
modifications are used in biological systems as information carriers, helping regulate organization on the cell surface
and interactions between cells and the environment. Galectins are a family of carbohydrate binding proteins that
bind to polysaccharides containing a galactose. Galectins have the ability to crosslink glycosylated proteins –
especially on the cell surface – giving galectins a role in modulating cell signalling and environmental interactions,
influencing angiogenesis, immune regulation and cell adhesion. This implicates galectins in diseases like cancer
and immune related disorders. Subsequently, many glycomimetics have been developed as galectin inhibitors,
based on a variety of scaffolds, many with very high affinities, but selectivity between galectins remains a challenge.
The galectin family of proteins has a very conserved binding motif, hence the differences in the binding pocket are
small, making designing a selective inhibitor a challenge.
We investigated C1-galactosides as possible galectin inhibitor scaffolds, exploiting one of the few differences
between galectin-1 and galectin-3 – histidine 52. We used C1-arylheterocycles to control the selectivity via the
interaction between the anomeric heterocycle and the histidine, an approach which turned out to be fruitful resulting
in the inhibitors 1-naphthyloxazole galactose, a galectin-3 selective inhibitor with 90μM affinity and 2-
fluorophenyltriazole galactose, a galectin-1 selective inhibitor with a 170 μM affinity with fivefold and eightfold
selectivity respectively. Extending the C1- system with a methylene linker resulted in the galectin-1 selective 4-
fluorophenyltriazole 2-deoxygalactoheptulose, an inhibitor with 170 μM affinity and fourfold selectivity. In order to
pursue these 2-deoxyheptulose scaffolds we developed a diastereoselective hydroboration method for C1-
exomethylene glycopyranosides. Combining C1-substitutions with substitution in position three on galactose with a
phenyltriazole motif did not increase affinities in a straightforward way; instead of increasing affinity and perserving
selectivity patterns set by the C1-substitutents, the disubstituted molecules emerged as galectin-4 selective
inhibitors with affinities down to 2.3 μM and up to thirty-eightfold or better selectivity for galectin-4. This shows that
C1-galactosides can be selective galectin inhibitors with good affinities, but more work needs to be done to
understand the interaction between substitution patterns. We also investigated aminpyrimidine substituted
galactosides and identified compounds with a threehundred-fold selectivity for galectin-3 over galectin-1 and
affinities down to 1.7 μM. These results show that careful selection of heterocycles with an aim towards exploiting
even minute differences in the binding pocket can be effective in achieving selectivity.

Abstract (Swedish)

Carbohydrates are involved in many cellular processes, and most biomolecules are glycosylated. These
modifications are used in biological systems as information carriers, helping regulate organization on the cell surface
and interactions between cells and the environment. Galectins are a family of carbohydrate binding proteins that
bind to polysaccharides containing a galactose. Galectins have the ability to crosslink glycosylated proteins –
especially on the cell surface – giving galectins a role in modulating cell signalling and environmental interactions,
influencing angiogenesis, immune regulation and cell adhesion. This implicates galectins in diseases like cancer
and immune related disorders. Subsequently, many glycomimetics have been developed as galectin inhibitors,
based on a variety of scaffolds, many with very high affinities, but selectivity between galectins remains a challenge.
The galectin family of proteins has a very conserved binding motif, hence the differences in the binding pocket are
small, making designing a selective inhibitor a challenge.
We investigated C1-galactosides as possible galectin inhibitor scaffolds, exploiting one of the few differences
between galectin-1 and galectin-3 – histidine 52. We used C1-arylheterocycles to control the selectivity via the
interaction between the anomeric heterocycle and the histidine, an approach which turned out to be fruitful resulting
in the inhibitors 1-naphthyloxazole galactose, a galectin-3 selective inhibitor with 90μM affinity and 2-
fluorophenyltriazole galactose, a galectin-1 selective inhibitor with a 170 μM affinity with fivefold and eightfold
selectivity respectively. Extending the C1- system with a methylene linker resulted in the galectin-1 selective 4-
fluorophenyltriazole 2-deoxygalactoheptulose, an inhibitor with 170 μM affinity and fourfold selectivity. In order to
pursue these 2-deoxyheptulose scaffolds we developed a diastereoselective hydroboration method for C1-
exomethylene glycopyranosides. Combining C1-substitutions with substitution in position three on galactose with a
phenyltriazole motif did not increase affinities in a straightforward way; instead of increasing affinity and perserving
selectivity patterns set by the C1-substitutents, the disubstituted molecules emerged as galectin-4 selective
inhibitors with affinities down to 2.3 μM and up to thirty-eightfold or better selectivity for galectin-4. This shows that
C1-galactosides can be selective galectin inhibitors with good affinities, but more work needs to be done to
understand the interaction between substitution patterns. We also investigated aminpyrimidine substituted
galactosides and identified compounds with a threehundred-fold selectivity for galectin-3 over galectin-1 and
affinities down to 1.7 μM. These results show that careful selection of heterocycles with an aim towards exploiting
even minute differences in the binding pocket can be effective in achieving selectivity.

• author: Dahlqvist, Alexander
• supervisor: Ulf Nilsson
• opponent: Professor Somsák, László, University of Debrecen, Debrecen, Hungary
• organization: Centre for Analysis and Synthesis
• alternative title: Nya monogalaktosidbaserade galektinhämmarstrukturramverk : Att påverka selektivitet med heteroaromatiska interaktioner
• publishing date: 2019-04-25
• type: Thesis
• publication status: published
• subject: Organic Chemistry
• keywords: Galectin, Galectin inhibitor, Heterocycles, C-glycoside, Medicinal chemistry, Organic chemistry, Hydroboration, Diastereoselective, Galactose
• volume: 1
• edition: 1
• pages: 106 pages
• defense location: Lecture hall A, Center for Chemistry and Chemical Engineering, Naturvetarvägen 14, Lund
• defense date: 2019-05-29 09:00:00
• ISBN: 978-91-7422-658-4
• ISBN: 978-91-7422-659-1
• language: English
• LU publication?: yes
• id: 56fbe79b-566b-491d-8b05-5af5580c57b6
• date added to LUP: 2019-04-26 12:13:55
• date last changed: 2022-06-15 09:36:32